BALLENTINE PARTNERS, LLC Vertex Pharmaceuticals Incorporated Transaction History

BALLENTINE PARTNERS, LLC portfolio value:

$584,000
portfolio value

BALLENTINE PARTNERS, LLC quarter portfolio value change:

+2.75%
quarter

Vertex Pharmaceuticals Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +33.33% 504 shares 158K $289.54 2.01K
Q2 2022 share Increase +9.49% 131 shares 66K $281.79 1.51K
Q1 2022 share Decrease -16.81% -279 shares -4K $260.97 1.38K
Q4 2021 share Increase 0.00% 1.66K shares 364K $222.45 1.66K
Q3 2021 share Decrease -100.00% -1.02K shares -206K $181.39 0
Q2 2021 share Decrease -7.59% -84 shares -32K $201.63 1.02K
Q1 2021 share Decrease -10.36% -128 shares -53K $214.89 1.10K
Q4 2020 share Decrease -15.53% -227 shares -107K $236.34 1.23K
Q3 2020 share Increase +1.11% 16 shares -22K $272.12 1.46K
Q2 2020 share Decrease -3.28% -49 shares 64K $290.31 1.44K
Q1 2020 share Increase +5.95% 84 shares 47K $237.95 1.49K
Q4 2019 share Increase +4.29% 58 shares 79K $218.95 1.41K
Q3 2019 share Decrease -0.59% -8 shares -20K $169.42 1.35K
Q2 2019 share Increase 0.00% 1.36K shares 250K $183.38 1.36K
Q4 2017 share Decrease -100.00% -1.82K shares -277K $149.86 0
Q3 2017 share Decrease -0.16% -3 shares -18K $152.04 1.82K
Q2 2017 share Increase 0.00% 1.82K shares 295K $128.87 1.82K